FOM Technologies

FOM Technologies subsidiary MLMC Therapeutics files its first patent application

2.7.2020 17:00:01 CEST | FOM Technologies | Investor News

Investor news nr. 1 – 2020 Copenhagen, the 2nd of July 2020

FOM Technologies A/S’ 51% owned subsidiary MLMC Therapeutics ApS has filed its first patent application. The patent application is related to Slot Die coating process manufacturing of oral medicine.

The 51 % owned subsidiary MLMC Therapeutics has filed a patent application with the Danish patent and trademark office. The company was established to execute research and development within process manufacturing of oral medicine. At present, the company has no commercial activity.


MLMC Therapeutics ApS is a subsidiary of FOM Technologies A/S. The company was established to do research and development within process manufacturing of oral medicine. The company has no commercial activity at present.
For more information, please visit:


FOM Technologies A/S provides premium Slot Die equipment for advanced material researchers at leading universities, research institutions and corporate laboratories around the world. The company was founded as a spinout from DTU (Danish Technical University) in 2012, to support a  niche market of organic photovoltaics (OPV) research with its highly precise and scalable thin film production platform. The company has grown since its founding, with its 2020 market presence extending well beyond OPV into perovskite photovoltaics, advanced batteries, supercapacitors, touch-sensitive surfaces, microfluidic medical analysis, drug delivery and more. With 100% export to customers in over 20 countries FOM Technologies A/S is a true “born global” SME with worldwide impact based in the heart of Copenhagen, Denmark.

FOM Technologies A/S with ticker code “FOM” is listed on Nasdaq First North Growth Market Denmark. For more information, please visit:


FOM Technologies A/S
CEO Michael Stadi
Tlf: +45 20 66 60 44

Certified Advisor:
Norden CEF ApS
John Norden
Tlf: +45 20 72 02 00


Future projections reflect FOM Technologies’ current expectation for upcoming market trends and results. FOM Technologies aims to deliver projections based on reliable, fact-based market analysis. However, FOM Technologies can by no means guarantee the fruition of any such projected outcomes. FOM Technologies will not be held liable for negative or unexpected outcomes associated with the inherent risks of projection-based investments, which are influenced by a wide variety of external uncertainties and factors beyond our control.



Subscribe to our company announcements

Keep up to date with our company announcements by subscribing.

Visit our pressroom and see more company announcements from us.

Our pressroom